SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001720725-21-000023
Filing Date
2021-02-18
Accepted
2021-02-18 16:02:48
Documents
75
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K oyst-20201231.htm   iXBRL 10-K 1829457
2 EX-10.9 exhibit109.htm EX-10.9 40626
3 EX-23.1 q4-20ex231.htm EX-23.1 2643
4 EX-31.1 q4-20ex311.htm EX-31.1 13243
5 EX-31.2 q4-20ex312.htm EX-31.2 12744
6 EX-32.1 q4-20ex321.htm EX-32.1 7533
7 EX-32.2 q4-20ex322.htm EX-32.2 7528
13 oyst-20201231_g1.jpg GRAPHIC 15544
14 oyst-20201231_g2.jpg GRAPHIC 57309
15 oyst-20201231_g3.jpg GRAPHIC 165718
16 oyst-20201231_g4.jpg GRAPHIC 28385
  Complete submission text file 0001720725-21-000023.txt   7755131

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oyst-20201231.xsd EX-101.SCH 37969
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oyst-20201231_cal.xml EX-101.CAL 78129
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oyst-20201231_def.xml EX-101.DEF 167547
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oyst-20201231_lab.xml EX-101.LAB 559173
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oyst-20201231_pre.xml EX-101.PRE 366655
17 EXTRACTED XBRL INSTANCE DOCUMENT oyst-20201231_htm.xml XML 1094164
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39112 | Film No.: 21649464
SIC: 2836 Biological Products, (No Diagnostic Substances)